Greg Garfield

Greg Garfield is an executive with extensive experience in running medical technology companies, including managing and leading people at all levels, as well operational management and business strategy and planning. Originally an attorney at Pillsbury Winthrop, Greg began his medical technology career at Guidant Corporation where he held a number of executive-level legal and business development positions in different Guidant operating companies. Following Guidants acquisition by Boston Scientific, Greg joined Acclarent, Inc. where he served initially as Vice President of Corporate Development, and then as Acclarents Chief Operating Officer through the acquisition and integration of Acclarent by Ethicon, Inc., a Johnson & Johnson company. In addition to RODO Medical, Greg currently serves on the Board of Directors of Sonitus Medical, C2 Therapeutics, and Aerin Medical.